-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the State Drug Administration's first quarter of 2021 drug supervision and management statistical report, as of the end of March 2021, there were a total of 580,800 "drug business license" licensees across the country
.
Among them, there are 13,200 wholesale companies, 6,593 retail chain headquarters, 319,100 retail chain stores, and 241,900 single drug stores
.
Compared with 2020, in the first quarter of 2021, there will be an additional 7,100 pharmacies nationwide
.
It is obvious from the increasing number of pharmacies that China's pharmaceutical retail industry is showing a prosperous trend
.
In fact, the prosperity of China's pharmaceutical retail industry has indeed been continuously improving in recent years
.
In particular, under the favorable conditions of policy guidance, health industry upgrades, and changes in consumer demand, the industry predicts that the prospects of China's pharmaceutical retail industry will be very impressive
.
Especially with the help of policies, the development of China's pharmaceutical retail industry will be further promoted
.
Industry analysts believe that the "Interim Measures for the Management of Medical Security Designated Points for Medical Institutions" and "Interim Measures for the Management of Medical Security Designated Points for Retail Pharmacies" issued at the beginning of this year clarify the basic conditions and procedures for medical institutions and retail pharmacies to be included in medical insurance designated points, and they will serve as medical institutions.
The designated management of retail pharmacies is moving towards standardization and legalization, creating further favorable conditions for retail pharmacies to participate in fair market competition
.
In addition, at the end of last year, the state included "urging local governments to clean up unreasonable conditions such as spacing restrictions on the opening of pharmacies" into the key tasks of deepening the reform of "decentralization, regulation and service" and optimizing the business environment, leading many localities to take active actions and abolish pharmacies.
The "spacing threshold" will also continue to stimulate the vitality of market competition, help the healthy development of the pharmacy industry, and bring more benefits to consumers
.
However, it should be noted that under the background of policy guidance, health industry upgrades, and changes in consumer demand that promote the acceleration of the development of the pharmaceutical retail industry, this market is actually facing many new challenges
.
For example, industry competition is intensifying, and pharmaceutical e-commerce and foreign forces are accelerating their entry into the pharmaceutical retail industry
.
Among them, it is worth mentioning that the large-scale pharmaceutical retail chain companies are continuing to "enclose the market", which is becoming the main factor that intensifies the concentration of the industry.
.
It is reported that the common people's pharmacy issued an announcement earlier that it plans to raise no more than 1.
74 billion yuan and will use the points for new chain pharmacies and corporate digital platforms
.
In addition, at the previous 2020 annual general meeting of shareholders, Feng Pharmacy also proposed that “the company plans to enter one new province in the past two years, and two new provinces within three years, with a new store opening rate of greater than or equal to 2,000 each year
.
Based on the above, Analysts believe that competition in the pharmaceutical retail market is expected to become more intense
in the future .
In this context, the development of small and medium-sized retail pharmacies will face more challenges
.
In this regard, the industry believes that relevant pharmacies must obtain For more development opportunities, it is necessary to accelerate the extension to service and medical; in addition, it is necessary to continuously upgrade the scale and professional service capabilities to not be easily eliminated by fierce market competition
.
.
Among them, there are 13,200 wholesale companies, 6,593 retail chain headquarters, 319,100 retail chain stores, and 241,900 single drug stores
.
Compared with 2020, in the first quarter of 2021, there will be an additional 7,100 pharmacies nationwide
.
It is obvious from the increasing number of pharmacies that China's pharmaceutical retail industry is showing a prosperous trend
.
In fact, the prosperity of China's pharmaceutical retail industry has indeed been continuously improving in recent years
.
In particular, under the favorable conditions of policy guidance, health industry upgrades, and changes in consumer demand, the industry predicts that the prospects of China's pharmaceutical retail industry will be very impressive
.
Especially with the help of policies, the development of China's pharmaceutical retail industry will be further promoted
.
Industry analysts believe that the "Interim Measures for the Management of Medical Security Designated Points for Medical Institutions" and "Interim Measures for the Management of Medical Security Designated Points for Retail Pharmacies" issued at the beginning of this year clarify the basic conditions and procedures for medical institutions and retail pharmacies to be included in medical insurance designated points, and they will serve as medical institutions.
The designated management of retail pharmacies is moving towards standardization and legalization, creating further favorable conditions for retail pharmacies to participate in fair market competition
.
In addition, at the end of last year, the state included "urging local governments to clean up unreasonable conditions such as spacing restrictions on the opening of pharmacies" into the key tasks of deepening the reform of "decentralization, regulation and service" and optimizing the business environment, leading many localities to take active actions and abolish pharmacies.
The "spacing threshold" will also continue to stimulate the vitality of market competition, help the healthy development of the pharmacy industry, and bring more benefits to consumers
.
However, it should be noted that under the background of policy guidance, health industry upgrades, and changes in consumer demand that promote the acceleration of the development of the pharmaceutical retail industry, this market is actually facing many new challenges
.
For example, industry competition is intensifying, and pharmaceutical e-commerce and foreign forces are accelerating their entry into the pharmaceutical retail industry
.
Among them, it is worth mentioning that the large-scale pharmaceutical retail chain companies are continuing to "enclose the market", which is becoming the main factor that intensifies the concentration of the industry.
.
It is reported that the common people's pharmacy issued an announcement earlier that it plans to raise no more than 1.
74 billion yuan and will use the points for new chain pharmacies and corporate digital platforms
.
In addition, at the previous 2020 annual general meeting of shareholders, Feng Pharmacy also proposed that “the company plans to enter one new province in the past two years, and two new provinces within three years, with a new store opening rate of greater than or equal to 2,000 each year
.
Based on the above, Analysts believe that competition in the pharmaceutical retail market is expected to become more intense
in the future .
In this context, the development of small and medium-sized retail pharmacies will face more challenges
.
In this regard, the industry believes that relevant pharmacies must obtain For more development opportunities, it is necessary to accelerate the extension to service and medical; in addition, it is necessary to continuously upgrade the scale and professional service capabilities to not be easily eliminated by fierce market competition
.
